🇺🇸 FDA
Patent

US 11274305

Compositions and methods for in vivo excision of HIV-1 proviral DNA

granted A61KA61K31/7105A61K38/1709

Quick answer

US patent 11274305 (Compositions and methods for in vivo excision of HIV-1 proviral DNA) held by United States Government as represented by the Department of Veterans Affairs expires Mon Mar 10 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
United States Government as represented by the Department of Veterans Affairs
Grant date
Tue Mar 15 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 10 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K31/7105, A61K38/1709